Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis
Journal of Clinical Apheresis · 2023-02 · 38 (1) · 4-15
DOI: 10.1002/jca.22018 ↗At a glance
Metaanalyse in Journal of Clinical Apheresis, published online on 2022-09-24. Written by Li-Hong Yan and 6 co-authors. Institution: Institute of Nephrology, Zhong da Hospital, Southeast University School of Medicine, Nanjing, China. Major MEDLINE topics: Pancreatitis, Hypertriglyceridemia. Cited 25 times so far (Crossref); 35 references. Funded by: Southeast University.
Abstract (original language)
Background
The treatment of acute pancreatitis (AP) induced by hypertriglyceridemia (HTG) remains controversial with regard to plasmapheresis vs conventional treatment. We reviewed relevant articles to explore the efficacy of plasmapheresis in the management of HTG‐induced AP.
Methods
We systematically reviewed studies that compared plasmapheresis with conventional treatment for HTG‐induced AP using three databases: PubMed, Embase, and Cochrane Library, as well as relevant references. The primary outcomes were 24 h triglyceride reduction rate and in‐hospital mortality.
Results
A total of 791 articles were retrieved. Finally, 15 observational studies (1080 participants) were included, most of which were historical cohort studies. Compared with conventional treatment, plasmapheresis assisted in the reduction of serum triglyceride (TG) levels in the first 24 h after hospital admission (standardized mean difference [SMD]: 0.58; 95% confidence interval [CI]: 0.17 to 0.99; P = 0.005). However, it resulted in increased hospitalization costs (thousand yuan) (weighted mean difference [WMD]: 24.32; 95% CI: 12.96 to 35.68; P < 0.001). With regard to in‐hospital mortality, although the mortality rate in the plasmapheresis group was higher than that in the conventional treatment group (relative risk [RR]: 1.74; 95% CI: 1.03 to 2.94; P = 0.038), the result was disturbed by confounding factors as per the subgroup and sensitivity analysis, as well as trial sequential analysis (TSA). No significant differences were found in other outcomes, including systematic complications, local complications, the requirement for surgery, and hospitalization duration.
Conclusion
The effect of plasmapheresis in HTG‐induced AP is not superior to that of conventional treatment, even resulting in a greater economic burden to patients and health care system. High quality randomized control trials are required to obtain a more a definitive understanding of this issue.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Nephrology, Zhong da Hospital, Southeast University School of Medicine, Nanjing, China.
ORCID profiles: Li-Hong Yan
Funding
- Southeast University
Cite
APA
Yan, L. H., Hu, X. H., Chen, R. X., Pan, M. M., Han, Y. C., Gao, M., & Liu, H. (2023). Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis. Journal of Clinical Apheresis, 38(1), 4-15. https://doi.org/10.1002/jca.22018
Vancouver
Yan LH, Hu XH, Chen RX, Pan MM, Han YC, Gao M, et al. Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis. Journal of Clinical Apheresis. 2023;38(1):4-15. doi:10.1002/jca.22018
BibTeX
@article{Yan2023,
author = {Yan, Li-Hong and Hu, Xin-Hui and Chen, Ruo-Xin and Pan, Ming-Ming and Han, Yu-Chen and Gao, Min and Liu, Hong},
title = {Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis},
journal = {Journal of Clinical Apheresis},
year = {2023},
volume = {38},
number = {1},
pages = {4--15},
doi = {10.1002/jca.22018}
}
EUVIMED